GLMD Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company. It is engaged in the development and commercialization of oral therapy for the treatment of liver diseases and cholesterol gallstones.

$0.31
As of 12/02/2022     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Israel
Country of incorporation:  
IPO date:  03/13/2014
Outstanding shares:  25,088,414
Average volume:  33,567
Market cap:   $7,526,524
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Sedol:      
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.30
PS ratio:   0.00
Return on equity:   -106.46%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy